- Home
- ARMN vs TWST Comparison
ARMN vs TWST Comparison
Compare ARMN & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARMN
- TWST
- Stock Information
- Founded
- ARMN 1992
- TWST 2013
- Country
- ARMN Canada
- TWST United States
- Employees
- ARMN N/A
- TWST N/A
- Industry
- ARMN
- TWST Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ARMN
- TWST Health Care
- Exchange
- ARMN Nasdaq
- TWST Nasdaq
- Market Cap
- ARMN 2.0B
- TWST 2.1B
- IPO Year
- ARMN N/A
- TWST 2018
- Fundamental
- Price
- ARMN $9.34
- TWST $32.21
- Analyst Decision
- ARMN Strong Buy
- TWST Buy
- Analyst Count
- ARMN 1
- TWST 9
- Target Price
- ARMN $17.00
- TWST $48.56
- AVG Volume (30 Days)
- ARMN 1.4M
- TWST 1.9M
- Earning Date
- ARMN 10-29-2025
- TWST 11-14-2025
- Dividend Yield
- ARMN N/A
- TWST N/A
- EPS Growth
- ARMN N/A
- TWST N/A
- EPS
- ARMN 0.02
- TWST N/A
- Revenue
- ARMN $646,783,000.00
- TWST $362,273,000.00
- Revenue This Year
- ARMN $73.48
- TWST $22.10
- Revenue Next Year
- ARMN $56.35
- TWST $16.61
- P/E Ratio
- ARMN $373.13
- TWST N/A
- Revenue Growth
- ARMN 38.72
- TWST 22.72
- 52 Week Low
- ARMN $3.29
- TWST $24.07
- 52 Week High
- ARMN $11.24
- TWST $55.33
- Technical
- Relative Strength Index (RSI)
- ARMN 45.05
- TWST 53.60
- Support Level
- ARMN $8.75
- TWST $30.36
- Resistance Level
- ARMN $10.03
- TWST $35.13
- Average True Range (ATR)
- ARMN 0.48
- TWST 2.39
- MACD
- ARMN -0.21
- TWST 0.11
- Stochastic Oscillator
- ARMN 23.69
- TWST 58.35
About ARMN Aris Mining Corporation
Aris Mining Corp is engaged in the acquisition, exploration, development, and operation of gold properties in Colombia, Guyana, and Canada. It owns and operates its Segovia Operations, Soto Norte Project and Marmato Mine in Colombia, the Toroparu Project in Guyana, and the Juby Project in Ontario, Canada. The company generates revenue from the sale of gold and silver.
About TWST Twist Bioscience Corporation
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.